Full name
The IMAGINE Study: A Phase 3b Open Label, Single Arm Study to Assess the Effect of Depemokimab on Airway Structure and Function in Asthma With Type 2 Inflammation Characterized by an Eosinophilic Phenotype Utilizing Quantitative High-resolution CT and Bronchoscopic Airway Sampling in a Sub Study
NCT Number
NCT06979323
Geography
US
Locations
United States
Primary Endpoints
Mean Change from Baseline in Total Mucus Plug Volume Measured at Total Lung Capacity (TLC) at Week 26
External Link
https://clinicaltrials.gov/study/NCT06979323
Order
7
Disease
Version
Phase
3
Status
Recruiting